Results for “ ”

Entry Author Date Location
McGuire, Bosley, Watson, & More at Our Health Summit—Register Today 10/26/15 Boston
Vertex, CRISPR Tx Team up on Gene Editing Drugs in $105M Pact 10/26/15 Boston
East Coast Biotech Roundup: Cancer Vaccines, Biogen, LabCentral & More 10/23/15 Boston
With New Startup, Caperna, Moderna Gets in on Cancer Vaccine Buzz 10/22/15 Boston
Gene Therapy Startup Dimension Cuts Price But Bags $72M in IPO 10/21/15 Boston
LabCentral Backers Planning $150M Venture Fund For Biotech Startups 10/21/15 Boston
Biogen to Cut 400 Jobs in Massachusetts in Big Restructuring 10/21/15 Boston
Cancer Vaccines Back in Vogue as VCs Put $102M Into Gritstone Oncology 10/20/15 San Francisco
What’s Your DNA Worth? The Scramble To Cash In On the Genome 10/20/15 National
Genocea Ditches Pneumococcus Vaccine After Phase 2 Flop, Shares Fall 10/19/15 Boston
To Curb Brain Damage, Astrocyte Pharmaceuticals Energizes Cells 10/19/15 Texas
East Coast Biotech Roundup: Zafgen, Decibel, Voyager & More 10/16/15 Boston
FDA Puts a Hold on Zafgen’s Obesity Drug, Shares Slide 10/16/15 Boston
PTC Unveils Mixed Duchenne Results, But Plots an FDA Filing 10/15/15 New York
Third Rock, SR One Put $52M Into Decibel to Battle Hearing Loss 10/15/15 Boston
Breaking Silence, Zafgen Reveals Patient Died During Obesity Trial 10/14/15 Boston
Voyager Charts an IPO Course Amid Choppy Biotech Waters 10/11/15 Boston
East Coast Biotech Roundup: Collins, Disruptors, Biogen, & More 10/09/15 Boston
Wyss Scientists Launch Opsonix With $8M to Fight Blood-Borne Bugs 10/08/15 Boston
No Drug Yet In Clinic, But CytomX Raises $80M In Discounted IPO 10/08/15 San Francisco
Genocea Climbs on Follow-Up Data for Herpes Vaccine 10/07/15 Boston
Amid Nobel Prize Suspense, Making Sense Of Latest Gene-Editing News 10/06/15 National
Boston’s Life Science Disruptors 2015: The Photos 10/06/15 Boston
From Dance Clubs to Syn Bio: MIT’s Collins on Startups, Second Chances 10/05/15 Boston
Five Takeaways From “Boston’s Life Science Disruptors” 10/02/15 Boston
East Coast Biotech Roundup: Forum, Neon, Sarepta, Accelerator & More 10/02/15 Boston
With $55M, Neon Wants To Make the Cancer Vaccine “Problem” Personal 10/01/15 Boston
Dunsire, Forum Search For Answers After FDA Halts Alzheimer’s Trial 09/29/15 Boston
Amid Biotech Swoon, Third Rock’s MyoKardia Tees up IPO 09/28/15 San Francisco
Verastem Sinks as Mesothelioma Study Halted For Futility 09/28/15 Boston
Page 2 of 102 « previous page · next page »